FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136812833> ?p ?o ?g. }

• W2136812833 endingPage "1436" @default.
• W2136812833 startingPage "1428" @default.
• W2136812833 abstract "The effects of cyclooxygenase-2 (cox-2) inhibition by a cox-2 selective antisense phosphorothioated oligonucleotide (AS) and meloxicam were examined in experimental colitis.Colitis was induced by trinitrobenzenesulphonic acid (TNBS) and acetic acid (Hac) separately in male Sprague-Dawley rats. Both groups of animals were treated daily intraperitoneally with AS and a mismatched control oligo (CO) (3 mg/kg), and orally with meloxicam (7.5 mg/kg) 1 h before induction of colitis. The animals were killed on day 4 (Hac) and on day 5 (TNBS). Tissue samples from colon, ileum, liver, kidney and spleen were collected for mRNA, myeloperoxidase activity (MPO), prostaglandin E2 (PGE2) estimation and for histology, and blood samples for PGE2, thromboxane B2 (TxB2) and TNF-alpha.Both TNBS and Hac increased colonic MPO activity, PGE2 concentrations and infiltration of colonic wall by inflammatory cells. Serum levels of TNF-alpha were increased in both models, whereas PGE2 was increased only in TNBS colitis. Only meloxicam suppressed the level of PGE2 significantly below the basal level. The animals in both models also showed splenomegaly. The colitis-induced changes were significantly suppressed by the treatment of the test compounds but not by the CO. Cox-2 mRNA but not cox-1 was decreased by the AS, but not by meloxicam or in CO-treated colitic animals.The findings demonstrate comparable beneficial effects of the cox-2 selective antisense oligonucleotide and meloxicam, which seem to be mediated by a combined inhibition of both PGE2 and TNF-alpha in the present models of colitis." @default.
• W2136812833 created "2016-06-24" @default.
• W2136812833 creator A5003496297 @default.
• W2136812833 creator A5018944500 @default.
• W2136812833 creator A5051831713 @default.
• W2136812833 creator A5071759111 @default.
• W2136812833 creator A5089849344 @default.
• W2136812833 date "2002-01-01" @default.
• W2136812833 modified "2023-10-06" @default.
• W2136812833 title "Cyclooxygenase-2 Inhibition and Experimental Colitis: Beneficial Effects of Phosphorothioated Antisense Oligonucleotide and Meloxicam" @default.
• W2136812833 cites W124172744 @default.
• W2136812833 cites W1501052117 @default.
• W2136812833 cites W1523941392 @default.
• W2136812833 cites W1906809867 @default.
• W2136812833 cites W1968219794 @default.
• W2136812833 cites W1968528184 @default.
• W2136812833 cites W1971310148 @default.
• W2136812833 cites W1994629635 @default.
• W2136812833 cites W1998803037 @default.
• W2136812833 cites W1999113871 @default.
• W2136812833 cites W2008395005 @default.
• W2136812833 cites W2011684562 @default.
• W2136812833 cites W2016932222 @default.
• W2136812833 cites W2017492998 @default.
• W2136812833 cites W2018584013 @default.
• W2136812833 cites W2019150627 @default.
• W2136812833 cites W2020358486 @default.
• W2136812833 cites W2023433628 @default.
• W2136812833 cites W2024065712 @default.
• W2136812833 cites W2026628125 @default.
• W2136812833 cites W2060333964 @default.
• W2136812833 cites W2072259978 @default.
• W2136812833 cites W2085378313 @default.
• W2136812833 cites W2085646442 @default.
• W2136812833 cites W2089923844 @default.
• W2136812833 cites W2095049902 @default.
• W2136812833 cites W2104524918 @default.
• W2136812833 cites W2118730797 @default.
• W2136812833 cites W2123282327 @default.
• W2136812833 cites W2129815268 @default.
• W2136812833 cites W2131030147 @default.
• W2136812833 cites W2139120649 @default.
• W2136812833 cites W2150082019 @default.
• W2136812833 cites W2163533899 @default.
• W2136812833 cites W2163756514 @default.
• W2136812833 cites W2170073548 @default.
• W2136812833 cites W2187213934 @default.
• W2136812833 cites W2242855051 @default.
• W2136812833 cites W2312652235 @default.
• W2136812833 cites W2406695751 @default.
• W2136812833 cites W2467116370 @default.
• W2136812833 cites W1980858407 @default.
• W2136812833 doi "https://doi.org/10.1080/003655202762671314" @default.
• W2136812833 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12523593" @default.
• W2136812833 hasPublicationYear "2002" @default.
• W2136812833 type Work @default.
• W2136812833 sameAs 2136812833 @default.
• W2136812833 citedByCount "21" @default.
• W2136812833 countsByYear W21368128332014 @default.
• W2136812833 countsByYear W21368128332015 @default.
• W2136812833 countsByYear W21368128332020 @default.
• W2136812833 crossrefType "journal-article" @default.
• W2136812833 hasAuthorship W2136812833A5003496297 @default.
• W2136812833 hasAuthorship W2136812833A5018944500 @default.
• W2136812833 hasAuthorship W2136812833A5051831713 @default.
• W2136812833 hasAuthorship W2136812833A5071759111 @default.
• W2136812833 hasAuthorship W2136812833A5089849344 @default.
• W2136812833 hasConcept C126322002 @default.
• W2136812833 hasConcept C181199279 @default.
• W2136812833 hasConcept C185592680 @default.
• W2136812833 hasConcept C203014093 @default.
• W2136812833 hasConcept C203565725 @default.
• W2136812833 hasConcept C2775862500 @default.
• W2136812833 hasConcept C2776914184 @default.
• W2136812833 hasConcept C2777956040 @default.
• W2136812833 hasConcept C2778260677 @default.
• W2136812833 hasConcept C2779134260 @default.
• W2136812833 hasConcept C2779689624 @default.
• W2136812833 hasConcept C2779751750 @default.
• W2136812833 hasConcept C2780931953 @default.
• W2136812833 hasConcept C2781080829 @default.
• W2136812833 hasConcept C55493867 @default.
• W2136812833 hasConcept C71924100 @default.
• W2136812833 hasConcept C89560881 @default.
• W2136812833 hasConcept C98274493 @default.
• W2136812833 hasConceptScore W2136812833C126322002 @default.
• W2136812833 hasConceptScore W2136812833C181199279 @default.
• W2136812833 hasConceptScore W2136812833C185592680 @default.
• W2136812833 hasConceptScore W2136812833C203014093 @default.
• W2136812833 hasConceptScore W2136812833C203565725 @default.
• W2136812833 hasConceptScore W2136812833C2775862500 @default.
• W2136812833 hasConceptScore W2136812833C2776914184 @default.
• W2136812833 hasConceptScore W2136812833C2777956040 @default.
• W2136812833 hasConceptScore W2136812833C2778260677 @default.
• W2136812833 hasConceptScore W2136812833C2779134260 @default.
• W2136812833 hasConceptScore W2136812833C2779689624 @default.
• W2136812833 hasConceptScore W2136812833C2779751750 @default.
• W2136812833 hasConceptScore W2136812833C2780931953 @default.

• next